A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)
Clinical trial NCT04728711 · COMPLETED
Trial details
- NCT number
- NCT04728711
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-09
- Primary completion
- 2022-01-18
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.